RESUMO
The first recorded human outbreak of Ebola virus was in 1976, but the wild reservoir of this virus is still unknown. Here we test for Ebola in more than a thousand small vertebrates that were collected during Ebola outbreaks in humans and great apes between 2001 and 2003 in Gabon and the Republic of the Congo. We find evidence of asymptomatic infection by Ebola virus in three species of fruit bat, indicating that these animals may be acting as a reservoir for this deadly virus.
Assuntos
Quirópteros/virologia , Reservatórios de Doenças/veterinária , Reservatórios de Doenças/virologia , Ebolavirus/isolamento & purificação , Doença pelo Vírus Ebola/virologia , Animais , Anticorpos Antivirais/análise , Anticorpos Antivirais/imunologia , Doenças dos Símios Antropoides/epidemiologia , Doenças dos Símios Antropoides/prevenção & controle , Doenças dos Símios Antropoides/transmissão , Doenças dos Símios Antropoides/virologia , Quirópteros/classificação , Quirópteros/imunologia , Congo/epidemiologia , Surtos de Doenças/veterinária , Ebolavirus/fisiologia , Gabão/epidemiologia , Gorilla gorilla/virologia , Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/imunologia , Doença pelo Vírus Ebola/veterinária , Humanos , Pan troglodytes/virologia , Estações do Ano , Zoonoses/epidemiologia , Zoonoses/transmissão , Zoonoses/virologiaRESUMO
BACKGROUND: Patients who have refused to provide blood samples has meant that there have been significant delays in confirming outbreaks of Ebola virus hemorrhagic fever (EVHF). During the 2 EVHF outbreaks in the Republic of Congo in 2003, we assessed the use of oral fluid specimens versus serum samples for laboratory confirmation of cases of EVHF. METHODS: Serum and oral fluid specimens were obtained from 24 patients with suspected Ebola and 10 healthy control subjects. Specimens were analyzed for immunoglobulin G antibodies by enzyme-linked immunosorbent assay (ELISA) and for Ebola virus by antigen detection ELISA and reverse-transcriptase polymerase chain reaction (RT-PCR). Oral fluid specimens were collected with a commercially available collection device. RESULTS: We failed to detect antibodies against Ebola in the oral fluid specimens obtained from patients whose serum samples were seropositive. All patients with positive serum RT-PCR results also had positive results for their oral fluid specimens. CONCLUSIONS: This study demonstrates the usefulness of oral fluid samples for the investigation of Ebola outbreaks, but further development in antibodies and antigen detection in oral fluid specimens is needed before these samples are used for filovirus surveillance activities in Africa.
Assuntos
Ebolavirus/isolamento & purificação , Doença pelo Vírus Ebola/epidemiologia , Saliva/virologia , Adulto , Idoso , Anticorpos Antivirais/sangue , Anticorpos Antivirais/isolamento & purificação , Antígenos Virais/sangue , Antígenos Virais/isolamento & purificação , Congo/epidemiologia , Surtos de Doenças , Doença pelo Vírus Ebola/imunologia , Doença pelo Vírus Ebola/virologia , Humanos , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sensibilidade e EspecificidadeRESUMO
Several countries spanning the equatorial forest regions of Africa have had outbreaks of Ebola hemorrhagic fever over the last three decades. This article is an overview of the many published investigations of how Ebola virus circulates in its natural environment, focusing on the viral reservoir, susceptible animal species, environmental conditions favoring inter-species transmission, and how the infection is transmitted to humans. Major breakthroughs have been made in recent years but many outstanding questions must be dealt with if we are to prevent human outbreaks by interfering with the viral life cycle.
Assuntos
Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/virologia , África/epidemiologia , Animais , Surtos de Doenças , Reservatórios de Doenças , Doença pelo Vírus Ebola/transmissão , Humanos , Doença do Vírus de Marburg/epidemiologiaRESUMO
Over the last 30 years, Zaire ebolavirus (ZEBOV), a virus highly pathogenic for humans and wild apes, has emerged repeatedly in Central Africa. Thus far, only a few virus isolates have been characterized genetically, all belonging to a single genetic lineage and originating exclusively from infected human patients. Here, we describe the first ZEBOV sequences isolated from great ape carcasses in the Gabon/Congo region that belong to a previously unrecognized genetic lineage. According to our estimates, this lineage, which we also encountered in the two most recent human outbreaks in the Republic of the Congo in 2003 and 2005, diverged from the previously known viruses around the time of the first documented human outbreak in 1976. These results suggest that virus spillover from the reservoir has occurred more than once, as predicted by the multiple emergence hypothesis. However, the young age of both ZEBOV lineages and the spatial and temporal sequence of outbreaks remain at odds with the idea that the virus simply emerged from a long-established and widespread reservoir population. Based on data from two ZEBOV genes, we also demonstrate, within the family Filoviridae, recombination between the two lineages. According to our estimates, this event took place between 1996 and 2001 and gave rise to a group of recombinant viruses that were responsible for a series of outbreaks in 2001-2003. The potential for recombination adds an additional level of complexity to unraveling and potentially controlling the emergence of ZEBOV in humans and wildlife species.
Assuntos
Animais Selvagens/virologia , Ebolavirus/genética , Ebolavirus/isolamento & purificação , Hominidae/virologia , Recombinação Genética , Animais , Doenças dos Símios Antropoides/virologia , Sequência de Bases , Congo/epidemiologia , República Democrática do Congo , Surtos de Doenças , Genes Virais , Geografia , Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/veterinária , Humanos , Dados de Sequência Molecular , Filogenia , Fatores de TempoRESUMO
All human Ebola virus outbreaks during 2001-2003 in the forest zone between Gabon and Republic of Congo resulted from handling infected wild animal carcasses. After the first outbreak, we created an Animal Mortality Monitoring Network in collaboration with the Gabonese and Congolese Ministries of Forestry and Environment and wildlife organizations (Wildlife Conservation Society and Programme de Conservation et Utilisation Rationnelle des Ecosystemes Forestiers en Afrique Centrale) to predict and possibly prevent human Ebola outbreaks. Since August 2001, 98 wild animal carcasses have been recovered by the network, including 65 great apes. Analysis of 21 carcasses found that 10 gorillas, 3 chimpanzees, and 1 duiker tested positive for Ebola virus. Wild animal outbreaks began before each of the 5 human Ebola outbreaks. Twice we alerted the health authorities to an imminent risk for human outbreaks, weeks before they occurred.
Assuntos
Doenças dos Símios Antropoides/virologia , Surtos de Doenças/veterinária , Ebolavirus/isolamento & purificação , Gorilla gorilla , Doença pelo Vírus Ebola/transmissão , Doença pelo Vírus Ebola/veterinária , Pan troglodytes , Zoonoses/virologia , Animais , Antígenos Virais/análise , Doenças dos Símios Antropoides/mortalidade , DNA Viral/química , DNA Viral/genética , República Democrática do Congo/epidemiologia , Ebolavirus/genética , Gabão/epidemiologia , Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/genética , Doença pelo Vírus Ebola/mortalidade , Humanos , Imuno-Histoquímica/veterinária , Reação em Cadeia da Polimerase/veterinária , Zoonoses/epidemiologiaRESUMO
During the 2001-2002 outbreak in Gabon, we observed that several dogs were highly exposed to Ebola virus by eating infected dead animals. To examine whether these animals became infected with Ebola virus, we sampled 439 dogs and screened them by Ebola virus-specific immunoglobulin (Ig) G assay, antigen detection, and viral polymerase chain reaction amplification. Seven (8.9%) of 79 samples from the 2 main towns, 15 (15.2%) of 99 samples from Mekambo, and 40 (25.2%) of 159 samples from villages in the Ebola virus-epidemic area had detectable Ebola virus-IgG, compared to only 2 (2%) of 102 samples from France. Among dogs from villages with both infected animal carcasses and human cases, seroprevalence was 31.8%. A significant positive direct association existed between seroprevalence and the distances to the Ebola virus-epidemic area. This study suggests that dogs can be infected by Ebola virus and that the putative infection is asymptomatic.